Skip Navigation



European Heart Journal Advance Access published online on March 21, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi216
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
26/10/951    most recent
ehi216v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Salehian, O.
Right arrow Articles by Chan, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salehian, O.
Right arrow Articles by Chan, K. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2005; all rights reserved

Editorial

Should brain natriuretic peptides be measured in patients with aortic valve disease?

Omid Salehian 1 and Kwan L. Chan 1*

1 University of Ottawa Heart Institute, 40 Ruskin Avenue, Ottawa, Ontario, Canada

* To whom correspondence should be addressed.
Kwan L. Chan, E-mail: kchan{at}ottawaheart.ca



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.